Padua Research Archive, l’archivio istituzionale della produzione scientifica dell’Università degli Studi di Padova, ha lo scopo di raccogliere, documentare, conservare e pubblicare, anche ad accesso aperto, i prodotti della ricerca dell’Ateneo. Padua Research Archive utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da Cineca.
EnglishTaken together, the results presented show that inhibitors of the serine/threonine kinase CK2 may be useful either as monotherapy or even more potent in combination therapy with the tyrosine kinase inhibitor, Imatinib, for the treatment of leukemias caused by the Bcr/Abl oncogene. In the preclinical model used here, we have shown that especially the combination of the two drugs may be useful in eradicating cells that appear to linger after the initial treatment with a single drug,
| Titolo: | Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2 |
| Autori: | |
| Data di pubblicazione: | 2007 |
| Rivista: | |
| Abstract: | Taken together, the results presented show that inhibitors of the serine/threonine kinase CK2 may be useful either as monotherapy or even more potent in combination therapy with the tyrosine kinase inhibitor, Imatinib, for the treatment of leukemias caused by the Bcr/Abl oncogene. In the preclinical model used here, we have shown that especially the combination of the two drugs may be useful in eradicating cells that appear to linger after the initial treatment with a single drug, |
| Handle: | http://hdl.handle.net/11577/1775627 |
| Appare nelle tipologie: | 01.01 - Articolo in rivista |
File in questo prodotto:
Copyright © 2020